GLUCOSE 5 % B.BRAUN
Sponsors
Assistance Publique Hopitaux De Paris, Axoltis Pharma
Conditions
Amyotrophic Lateral Sclerosis (ALS)Fulminant myocarditissubarachnoid hemorrhages of aneurysmal origin (HSAa)
Phase 2
A double-blind, randomized, placebo-controlled, multicentric, phase II study in adult patients with amyotrophic lateral sclerosis (ALS) to assess efficacy, safety, tolerability and pharmacokinetics of multiple intravenous infusions of NX210c.
Active, not recruitingCTIS2023-508895-13-00
Start: 2024-10-25Target: 80Updated: 2025-11-06
LEVOSAH - Pilot study comparing the effectiveness of adding treatment with Levosimendan to usual care for the management of the acute phase of aneurysmal subarachnoid hemorrhages
Not yet recruitingCTIS2024-514242-36-00
Target: 30Updated: 2025-09-16
Pulse corticosteroids or/and Immunoglobulins to treat fulminant Myocarditis: a double-blind randomized controlled adaptive trial (The CORIUM study)
Not yet recruitingCTIS2023-506599-28-01
Target: 120Updated: 2025-01-09